Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care

Journal of Urology

Volumn 197, Issue 2, 2017, Pages 296-301

  Chappidi, Meera R ^a   Kates, Max ^a   Stimson, C J ^a   Johnson, Michael H ^a   Pierorazio, Phillip M ^a   Bivalacqua, Trinity J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

continuity of patient care; cystectomy; patient readmission; postoperative care; urinary bladder neoplasms

Indexed keywords

ABSCESS; ACUTE KIDNEY FAILURE; ANEMIA; ARTICLE; BACTEREMIA; BLADDER CANCER; BLEEDING; CANCER PATIENT; CARDIOVASCULAR DISEASE; CATHETER INFECTION; CATHETER OCCLUSION; CLOSTRIDIUM INFECTION; CORONARY ARTERY DISEASE; CYSTECTOMY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; ELECTROLYTE DISTURBANCE; FEVER; FISTULA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL OBSTRUCTION; HEART INFARCTION; HEMATOMA; HEMATURIA; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; HYDRONEPHROSIS; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PYELONEPHRITIS; REGIONALIZATION; SEPSIS; SEROMA; SOCIAL STATUS; SURGICAL APPROACH; SURGICAL INFECTION; SURGICAL WOUND; URETER STRICTURE; URETHRA STENOSIS; URINARY TRACT INFECTION; WOUND DEHISCENCE; AGED; BLADDER; BLADDER TUMOR; ECONOMICS; FACTUAL DATABASE; FEMALE; HOSPITAL; HOSPITAL MORTALITY; MALE; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; RADIATION RESPONSE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; CYSTECTOMY; DATABASES, FACTUAL; FEMALE; HOSPITAL COSTS; HOSPITAL MORTALITY; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 85008221250     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2016.08.082     Document Type: Article

References (30)

1. 1 Hollenbeck, B.K., Miller, D.C., Taub, D., et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol, 174, 2005, 1231.
2. 2 Shabsigh, A., Korets, R., Vora, K.C., et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol, 55, 2009, 164.
3. 3 Stimson, C.J., Chang, S.S., Barocas, D.A., et al. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol, 184, 2010, 1296.
4. 4 Stitzenberg, K.B., Chang, Y., Smith, A.B., et al. Exploring the burden of inpatient readmissions after major cancer surgery. J Clin Oncol, 33, 2015, 455.
5. 5 Skolarus, T.A., Jacobs, B.L., Schroeck, F.R., et al. Understanding hospital readmission intensity after radical cystectomy. J Urol, 193, 2015, 1500.
6. 6 Hollenbeck, B.K., Taub, D.A., Miller, D.C., et al. The regionalization of radical cystectomy to specific medical centers. J Urol, 174, 2005, 1385.
7. 7 Black, P.C., Brown, G.A., Dinney, C.P., Should cystectomy only be performed at high-volume hospitals by high-volume surgeons?. Curr Opin Urol, 16, 2006, 344.
8. 8 Smaldone, M.C., Simhan, J., Kutikov, A., et al. Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. Urol Oncol, 31, 2013, 1663.
9. 9 Birkmeyer, J.D., Should we regionalize major surgery? Potential benefits and policy considerations. J Am Coll Surg, 190, 2000, 341.
10. 10 Stitzenberg, K.B., Sigurdson, E.R., Egleston, B.L., et al. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol, 27, 2009, 4671.
11. 11 Nielsen, M.E., Mallin, K., Weaver, M.A., et al. Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base. BJU Int, 114, 2014, 46.
12. 12 Zheng, C., Habermann, E.B., Shara, N.M., et al. Fragmentation of care after surgical discharge: non-index readmission after major cancer surgery. J Am Coll Surg, 222, 2016, 780.
13. 13 Kim, Y., Gani, F., Lucas, D.J., et al. Early versus late readmission after surgery among patients with employer-provided health insurance. Ann Surg, 262, 2015, 502.
14. 14 Ryoo, J.J., Kunitake, H., Frencher, S.K., et al. Continuity of care: readmission to the same hospital following gastric cancer resection. J Am Coll Surg, 209(suppl.), 2009, S16.
15. 15 Pak, J.S., Lascano, D., Kabat, D.H., et al. Patterns of care for readmission after radical cystectomy in New York State and the effect of care fragmentation. Urol Oncol, 33, 2015, 426.
16. 16 Tsai, T.C., Orav, E.J., Jha, A.K., Care fragmentation in the postdischarge period: surgical readmissions, distance of travel, and postoperative mortality. JAMA Surg, 150, 2015, 59.
17. 17 Gore, J.L., Lai, J., Gilbert, S.M., et al. Readmissions in the postoperative period following urinary diversion. World J Urol, 29, 2011, 79.
18. 18 Nayak, J., Holt, S., Wright, J., et al. The impact of readmissions to secondary hospitals on failure-to-rescue rates following major urologic cancer surgery. J Urol, 193(suppl.), 2015, e283 abstract MP24-18.
19. 19 Healthcare Cost and Utilization Project: Overview of the Nationwide Readmissions Database (NRD) 2012. Available at https://www.hcup-us.ahrq.gov/nrdoverview.jsp. Accessed March 18, 2016.
20. 20 Konety, B.R., Allareddy, V., Influence of post-cystectomy complications on cost and subsequent outcome. J Urol, 177, 2007, 280.
21. 21 Quan, H., Parsons, G.A., Ghali, W.A., Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care, 40, 2002, 675.
22. 22 Chappidi, M.R., Kates, M., Stimson, C.J., et al. Quantifying nonindex hospital readmissions and care fragmentation after major urologic oncology surgeries in a nationally representative sample. J Urol, 197, 2017, 235.
23. 23 Curtis, J.P., Schreiner, G., Wang, Y., et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol, 54, 2009, 903.
24. 24 Borker, R., Costs associated with adverse events in patients with metastatic renal cell carcinoma. J Med Econ, 17, 2014, 792.
25. 25 Jackson, K.L., Glasgow, R.E., Hill, B.R., et al. Does travel distance influence length of stay in elective colorectal surgery?. Dis Colon Rectum, 56, 2013, 367.
26. 26 Jackson, K.L., Glasgow, R.E., Mone, M.C., et al. Does travel distance influence length of stay in elective pancreatic surgery?. HPB (Oxford), 16, 2014, 543.
27. 27 Minnillo, B.J., Maurice, M.J., Schiltz, N., et al. Few modifiable factors predict readmission following radical cystectomy. Can Urol Assoc J, 9, 2015, E439.
28. 28 Harraz, A.M., Osman, Y., El-Halwagy, S., et al. Risk factors of hospital readmission after radical cystectomy and urinary diversion: analysis of a large contemporary series. BJU Int, 115, 2015, 94.
29. 29 Hu, J.C., Chughtai, B., O'Malley, P., et al. Perioperative outcomes, health care costs, and survival after robotic-assisted versus open radical cystectomy: a national comparative effectiveness study. Eur Urol, 70, 2016, 195.
30. 30 Gandaglia, G., Popa, I., Abdollah, F., et al. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. Eur Urol, 66, 2014, 561.